CD66e (CEACAM5) Antibody, anti-human, REAfinity™
Synonyms: CEA, Carcinoembryonic antigen, CEACAM5
RECOMBINANT
Clone:
REA1158 | II-7
Type of antibody:
Primary antibodies, Recombinant antibodies
Isotype:
recombinant human IgG1
Applications:
MICS, IF, IHC Glossary
External link icon
Quality Assurance Certified ProductSatisfaction
guaranteed
more »
Select a conjugate:

Related products for CD66e (CEACAM5) Antibody, anti-human, REAfinity™

MICS (MACSima Imaging Cyclic Staining) applications
FITC
PE
Fixation:
frozen – Acetone
Species tested:
human
Recommended dilution:
1:50
Data source:
Miltenyi Biotec
Compatible applications:
IF, IHC
Conjugate:
FITC
Used products:
130-120-344
Testing grade:
Fixation:
FFPE
Species tested:
human
Tissue used:
colon
Recommended dilution:
1:50
Data source:
Miltenyi Biotec
Compatible applications:
IF, IHC
Conjugate:
FITC
Used products:
130-120-344
Testing grade:
Description:
Immunofluorescence analysis of a formalin-fixed, paraffin embedded (FFPE) human colon. Before staining, antigens were retrieved using heat-induced epitope retrieval (HIER) at pH 9. The section was stained using CD66e (CEACAM5) Antibody, anti-human, FITC (green) for 10 min at room temperature. Nuclei were visualized with Hoechst™ (blue). Scale bar: 30 µm.

Application image
Fixation:
frozen – PFA
Species tested:
human
Tissue used:
colon
Recommended dilution:
1:50
Data source:
Miltenyi Biotec
Compatible applications:
IF, IHC
Conjugate:
FITC
Used products:
130-120-344
Testing grade:
Specifications for CD66e (CEACAM5) Antibody, anti-human, REAfinity™
Overview

Clone REA1158 recognizes the human CD66e (CEACAM5) antigen, also known as CEA (Carcinoembryonic antigen), a cell-surface-anchored glycoprotein, which is a member of the Ig superfamily. CD66e (CEACAM5) plays a role in in cell adhesion and contributes to tumorigenicity by inhibiting cellular differentiation. CD66e (CEACAM5) is used as an important tumor marker for colorectal and other carcinomas.

Additional information: Clone REA1158 displays negligible binding to Fc receptors.

Alternative names

CEA, Carcinoembryonic antigen, CEACAM5

Detailed product information

Technical specifications

Clone
REA1158
Clonality
monoclonal
Isotype
recombinant human IgG1
Host
human cell line
Type of antibody
Primary antibodies, Recombinant antibodies
Species reactivity
human
Antigen
CD66e (CEACAM5)
Distribution of antigen
epithelial cells
Entrez Gene ID
RRID
AB_2857524, AB_2857523

Recombinant antibodies at Miltenyi Biotec

As an innovation-powered company with a commitment to quality and excellence, Miltenyi Biotec applies cutting-edge methods to discover and develop newer and better antibodies to satisfy both market demand and regulatory requirements.

The Miltenyi way of generating best-in-class antibodies and antibody conjugates

At Miltenyi Biotec, we opt for recombinant antibodies, which enable sequence verification and optimization for lot-to-lot consistency, making them superior to hybridoma-based antibodies.

Infusing our unique expertise

Recombinants are the result of combining genetic material from different immunized animals, and using display technologies to screen in-house antibody libraries for the best antibodies. Additional analyses on existing hybridoma-based antibodies can also give rise to sequences contributing to novel recombinants.

Maximizing value for your research

By further re-engineering these antibody sequences, we can precisely control their properties to achieve the following benefits:

reduce undesirable binding to Fc gamma receptors,

  • eliminate destabilizing amino acid motifs,
  • increase specific bonding affinity for stronger, more accurate targeting, and
  • optimize fluorochrome conjugation for brighter and clearer signals.

In a final step, by synthesizing and cloning the resulting gene sequence, we achieve an expression vector that develops a cell line, which in turn produces a special recombinant antibody.

Better science with quality antibodies

Already in 2015, 100 of the world’s leading scientists collectively called for better standards and reproducibility in antibody production, proposing recombinant antibodies to circumvent variability (Baker, M. Reproducibility crisis: Blame it on the antibodies. Nature 521, 274–276 (2015). https://doi.org/10.1038/521274a). Moreover, by applying reverse engineering, which is encouraged by the EU Directive 2016/943 r, Miltenyi Biotec acts “[i]n the interest of innovation and fostering competition…” (§16).

Resources for CD66e (CEACAM5) Antibody, anti-human, REAfinity™
Certificates

To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.

Get certificate

Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.

Contact technical support

Citations for CD66e (CEACAM5) Antibody, anti-human, REAfinity™
Publications
  1. Hammarström, S. (1999) The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Semin. Cancer Biol. 9 (2): 67-81
  2. Taheri, M. et al. (2000) Self recognition in the Ig superfamily. Identification of precise subdomains in carcinoembryonic antigen required for intercellular adhesion. J. Biol. Chem. 275 (35): 26935-26943
  3. Boehm, M. K. and Perkins, S. J. (2000) Structural models for carcinoembryonic antigen and its complex with the single-chain Fv antibody molecule MFE23. FEBS Lett. 475 (1): 11-16

You have previously chosen International as your location.
What do you want to do?